Abstract
Factor XIII (FXIII) deficiency is a rare cause of bleeding and pregnancy loss that is easily treated with plasma products. Reliable assays for FXIII are necessary not only for the diagnosis of deficiency state but also to guide prophylaxis and replacement therapy in patients during times of increased risk. Diagnostic tests for FXIII activity whilst not technically demanding have a number of pitfalls including limited sensitivity and overestimation of activity at the lower end. Despite these shortcomings the performance of these assays is adequate for the diagnosis and management of the majority of patients with clinically significant deficiency.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ichinose A (2001) Physiopathology and regulation of factor XIII. Thromb Haemost 86:57–65
Ariens RA, Lai TS, Weisel JW, Greenberg CS, Grant PJ (2002) Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 100:743–754
Asahina T, Kobayashi T, Okada Y, Goto J, Terao T (2000) Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell. Placenta 21: 388–393
Peyvandi F, Mannucci PM (1999) Rare coagulation disorders. Thromb Haemost 82:1207–1214
Ivaskevicius V, Seitz R, Kohler HP, Schroeder V, Muszbek L, Ariens RA, Seifried E, Oldenburg J (2007) International registry on factor XIII deficiency: a basis formed mostly on European data. Thromb Haemost 97:914–921
Kloczko J, Wojtukiewicz M, Bielawiec M, Zarzycka B, Kinalska I (1986) Plasma factor XIII and some other haemostasis parameters in patients with diabetic angiopathy. Acta Haematol 76:81–85
Kloczko J, Wojtukiewicz M, Bielawiec M, Zuch A (1988) Alterations of haemostasis parameters with special reference to fibrin stabilization, factor XIII and fibronectin in patients with obliterative atherosclerosis. Thromb Res 51:575–581
Board PG, Losowsky MS, Miloszewski KJ (1993) Factor XIII: inherited and acquired deficiency. Blood Rev 7:229–242
Seitz R, Duckert F, Lopaciuk S, Muszbek L, Rodeghiero F, Seligsohn U (1996) ETRO Working Party on Factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives. Study Group. Semin Thromb Hemost 22:415–418
Bolton-Maggs PH, Perry DJ, Chalmers EA, Parapia LA, Wilde JT, Williams MD, Collins PW, Kitchen S, Dolan G, Mumford AD (2004) The rare coagulation disorders–review with guidelines for management from the United Kingdom Haemophilia Centre Doctors’ Organisation. Haemophilia 10: 593–628
Mitchell Lewis S, Bain BJ, Bates I (eds) (2006) Dacie and Lewis practical haematology, Vol. 1, 10th edn. Churchill Livingstone, Philadelphia
Jennings I, Kitchen S, Woods TA, Preston FE (2003) Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study. J Thromb Haemost 1:2603–2608
Ragaz S, Kemp G, Furlan M, Beck EA (1976) Bleeding disorder with abnormal wound healing, acid-soluble clots and normal factor XIII. Thromb Haemost 36:537–541
Dade-Behring (2005) Berichrom FXIII In: Reagents for the photometric determination of Factor XIII p6, Dade Behring, Marburg, Germany
Colman RW (ed) (2006) Hemostasis and thrombosis, basic principles and clinical practice, Vol. 1, 5th edn. Lippincott, Williams & Wilkins, Philadelphia
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Humana Press
About this protocol
Cite this protocol
Opat, S., Butler, J., Malan, E., Duncan, E., Tran, H.A.M. (2013). Factor XIII Assays. In: Monagle, P. (eds) Haemostasis. Methods in Molecular Biology, vol 992. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-339-8_13
Download citation
DOI: https://doi.org/10.1007/978-1-62703-339-8_13
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-338-1
Online ISBN: 978-1-62703-339-8
eBook Packages: Springer Protocols